![Jeffrey Hager](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jeffrey Hager was the founder of IDEAYA Biosciences, Inc. founded in 2015, where he held the title of Chief Technology Officer & Senior Vice President.
He held former positions as Associate Director-Biology at Apoptos, Inc. from 2008 to 2009, Director at Aragon Pharmaceuticals, Inc. in 2013 to 2014, Head-Cancer Pharmacology at Kalypsys, Inc. from 2004 to 2007, and Vice President-Biology at Seragon Pharmaceuticals, Inc. from 2014 to 2015.
Dr. Hager received his undergraduate degree from Connecticut College and Princeton University and his doctorate from the University of California, Berkeley.
Anciens postes connus de Jeffrey Hager
| Sociétés | Poste | Fin |
|---|---|---|
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Corporate Officer/Principal | 01/02/2015 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur/Membre du Conseil | 01/04/2014 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Corporate Officer/Principal | 01/04/2009 |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Corporate Officer/Principal | 01/11/2007 |
| IDEAYA BIOSCIENCES, INC. | Fondateur | - |
Formation de Jeffrey Hager
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Health Technology |
Connecticut College
 Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
